Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Anheuser-Busch Gears Up for Super Bowl Ad Game
Benoit Garbe, chief marketing officer at Anheuser-Busch, joined Cheddar News to discuss Super Bowl ads and what lies ahead after the company ended an exclusive deal with the big game last year.
Load More